Results 31 to 40 of about 1,581,172 (300)

Preferences for cancer investigation:a vignette-based study of primary-care attendees [PDF]

open access: yes, 2014
The UK lags behind many European countries in terms of cancer survival. Initiatives to address this disparity have focused on barriers to presentation, symptom recognition, and referral for specialist investigation.
Walter, Fiona M   +11 more
core   +1 more source

Abstract PO-150: Epidemiology of endometrial cancer as a second primary malignancy in Florida [PDF]

open access: yes, 2020
Background: According to cancer registry data, nearly 20% of Endometrial Cancer (EC) cases in the US are second or higher-order primary cancers. Little is known in regard to the epidemiology of EC as a Second Primary (ECSP) cancer.
Matthew P. Schlumbrecht   +5 more
core   +1 more source

Risks and cancer associations of metachronous and synchronous multiple primary cancers: a 25-year retrospective study

open access: yesBMC Cancer, 2021
Background The situation of patients developing multiple primary cancers is becoming more frequent and graver. This study investigated the risks of developing second primary cancers that are related to first primary cancers, and the interval times of ...
Pariyada Tanjak   +8 more
doaj   +1 more source

Impact of route to diagnosis on treatment intent and 1-year survival in patients diagnosed with oesophagogastric cancer in England: a prospective cohort study. [PDF]

open access: yes, 2013
OBJECTIVE: To investigate the relationship between the route to diagnosis, patient characteristics, treatment intent and 1 -year survival among patients with oesophagogastric (O-G) cancer.
Cromwell, David A   +6 more
core   +1 more source

Survival for endometrial cancer as a second primary malignancy [PDF]

open access: yes, 2022
Endometrial cancer (EC) often occurs subsequently to a primary cancer arising from a different site. However, little is known regarding the survival experience of EC as a second primary (ECSP) malignancy, specifically in relation to the original primary ...
Matthew P. Schlumbrecht   +7 more
core   +1 more source

Evaluation of the prevalence of metachronous second primary malignancies in hypopharyngeal carcinoma and their effect on outcomes

open access: yesCancer Medicine, 2022
Background To investigate the clinical characteristics of metachronous second primary malignancies (Met‐SPMs) and its impact on prognosis in hypopharyngeal carcinoma (HPC). Methods We reviewed 593 newly diagnosed HPC patients without invasive synchronous
Xi Luo   +15 more
doaj   +1 more source

Familial Risks and Mortality in Second Primary Cancers in Melanoma [PDF]

open access: yes, 2018
Background: Malignant melanoma (MM) patients are at increasing risk of developing second primary cancers (SPCs). We assessed mortality and risk of SPCs in MM patients with siblings or parents affected with same cancer compared with that of the general ...
Chattopadhyay, S   +11 more
core   +1 more source

Variation in risk of second primary cancer [PDF]

open access: yesCanadian Medical Association Journal, 2011
See related research article by Nielsen and colleagues on page [E57][1] and at [www.cmaj.ca/lookup/doi/10.1503/cmaj.110167][2] Second primary cancer is a major source of concern among cancer survivors, their families and the health care professionals providing follow-up care.
Marcy, Winget, Yutaka, Yasui
openaire   +2 more sources

Differences in breast cancer hormone receptor status in ethnic groups: a London population. [PDF]

open access: yes, 2013
BACKGROUND: Triple negative breast cancer (TNBC) is associated with different ethnic groups in the United States (US), however this has not previously been examined in a population-based study within the United Kingdom (UK). METHODS: Electronic pathology
Jack, Ruth H   +13 more
core   +1 more source

Latency Trend Analysis as a Guide to Screening Malignancy Survivors for Second Primary Thyroid Cancer [PDF]

open access: yes, 2022
Primary cancer survivors have a higher risk of developing second primary thyroid cancer (SPTC). Patients with SPTC who survived primary malignancies, diagnosed from 1975 to 2016, were identified from the Surveillance, Epidemiology, and End Results (SEER)
Toraih, Eman   +13 more
core   +2 more sources

Home - About - Disclaimer - Privacy